Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-19-031663
Filing Date
2019-05-24
Accepted
2019-05-24 09:24:51
Documents
12
Period of Report
2019-05-24

Document Format Files

Seq Description Document Type Size
1 6-K a19-10498_16k.htm 6-K 51340
2 GRAPHIC g104981bei001.gif GRAPHIC 575786
3 GRAPHIC g104981bei002.gif GRAPHIC 337135
4 GRAPHIC g104981bei003.gif GRAPHIC 498293
5 GRAPHIC g104981bei004.gif GRAPHIC 466121
6 GRAPHIC g104981bei005.gif GRAPHIC 358766
7 GRAPHIC g104981bei006.gif GRAPHIC 495200
8 GRAPHIC g104981bei007.gif GRAPHIC 416211
9 GRAPHIC g104981bei008.gif GRAPHIC 484008
10 GRAPHIC g104981bei009.gif GRAPHIC 242481
11 GRAPHIC g104981bei010.gif GRAPHIC 226548
12 GRAPHIC g104981bei011.gif GRAPHIC 49060
  Complete submission text file 0001104659-19-031663.txt   5767844
Mailing Address 1585 BROADWAY SUITE 2376 NEW YORK NY 10036
Business Address 1585 BROADWAY SUITE 2376 NEW YORK NY 10036 212-969-3335
Grifols SA (Filer) CIK: 0001438569 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-35193 | Film No.: 19852284
SIC: 2834 Pharmaceutical Preparations